A Phenomenological Comparison of LSD and Schizophrenic States
Abstract
The LSD and schizophrenic experiences are similar in more ways than they are different. The states are phenomenologically similar, but the similarity is contaminated by the fact that no significant differences exist between these two groups and the control group on several measures, if the phenomena in question are regarded as isolated. Significant differences exist between the LSD and schizophrenic experiences, primarily in the affective nature of the experiences and due to the presence of delusions in some schizophrenic states.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LSD and other serotonergic hallucinogens induce profound visual hallucinations, altered sense of self and time, but no consistent delusions.
“Contrary to ketamine, LSD and other serotonergic hallucinogens induce profound visual hallucinations, together with altered sense of self and time 21 but no consistent delusions.22”
From Are hallucinations due to an imbalance between excitatory and inhibitory influences on the brain? (2016) · cites this paper as [22]
Cites
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407 · see citing works
The Schizophrenia-like Psychoses of Epilepsy
Slater, E. T. O., & Beard, A. (1963) · The British Journal of Psychiatry · doi:10.1192/bjp.109.458.95 · Cited by 958 · see citing works
The Early Symptoms of Schizophrenia
Chapman, J. (1966) · British Journal of Psychiatry · doi:10.1192/bjp.112.484.225 · Cited by 675 · see citing works
A REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS
Osmond, H. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40738.x · Cited by 369 · see citing works
EXPERIMENTAL SCHIZOPHRENIA-LIKE SYMPTOMS
Rinkel, M., Deshon, H. J., Hyde, R. W., & Solomon, H. C. (1952) · American Journal of Psychiatry · doi:10.1176/ajp.108.8.572 · Cited by 114 · see citing works
Brody, E. B., Bellak, & Leopold, E. (1959) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195908000-00018 · Cited by 97 · see citing works
Mental changes experimentally produced by L. S. D. (d-Lysergic acid diethylamide tartrate)
Deshon, H. J., Rinkel, M., & Solomon, H. C. (1952) · Psychiatric Quarterly · doi:10.1007/bf01568448 · Cited by 76 · see citing works
LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND SCHIZOPHRENIC REACTIONS
LANGS, R. J., & Barr, H. L. (1968) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196808000-00008 · Cited by 44 · see citing works
Model Psychoses Induced by LSD-25 in Normals
Bercel, N. A. (1956) · A M A Archives of Neurology & Psychiatry · doi:10.1001/archneurpsyc.1956.02330240026003 · Cited by 35 · see citing works
The Effect of Two Hallucinogenic Agents on Human Retinal Function
Krill, A. E., Wieland, A., & OSTFELD, A. M. (1960) · Archives of Ophthalmology · doi:10.1001/archopht.1960.01840010726015 · Cited by 30 · see citing works
Research on the Effects of Isolation on Cognitive Functioning
Holt, R. R., & Goldberger, L. (1960) · PsycEXTRA Dataset · doi:10.1037/e528372009-001 · Cited by 10 · see citing works
Time perspective in schizophrenics
Schlosberg, A. (1969) · Psychiatric Quarterly · doi:10.1007/bf01564230 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
From drugs to deprivation: A Bayesian framework for understanding models of psychosis
Corlett, P. R., Frith, C. D., & Fletcher, P. C. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1561-0 · Cited by 367 · see citing works
“Acute LSD does not appear to induce delusions, at least consistently across subjects (Young 1974), although some subjects do experience a profound paranoia (Cohen 1966).”
BackgroundWaters, F., Collerton, D., ffytche, D. H., Jardri, R., Pins, D., Dudley, R., Blom, J. D., Mosimann, U. P., Eperjesi, F., Ford, S., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu036 · Cited by 325 · see citing works
“…a 40 a Holmboe and Astrup (1967)14 255 25 79 Jansson (1968)15 293 13 25 Goodwin et al (1971)16 45 59 82 Eggers (1973)17 a 44 71 McCabe (1976)18 40 20 36 Young (1974)19 20 45 a Zarroug (1975)20 69 47 62 Ciompi and Müller (1976)21 a 18 58 McCabe (1976)18 25 20 52 Deiker and Chambers (1978)22 28 64…”
Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes
Waters, F., & Fernyhough, C. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw132 · Cited by 315 · see citing works
Culture and the prevalence of hallucinations in schizophrenia
Bauer, S. M., Schanda, H., Karakuła‐Juchnowicz, H., Olajossy-Hilkesberger, L., Rudalevičienė, P., Okribelashvili, N., Chaudhry, H. R., Idemudia, E. S., Gscheider, S., Ritter, K. M., et al. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.06.008 · Cited by 242 · see citing works
The Disorder of Consciousness in Schizophrenia
Anscombe, R. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.241 · Cited by 225 · see citing works
Serotonin, schizophrenia and antipsychotic drug action
Breier, A. F. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00043-8 · Cited by 173 · see citing works
Are hallucinations due to an imbalance between excitatory and inhibitory influences on the brain?
Jardri, R., Hugdahl, K., Hughes, M., Brunelin, J., Waters, F., Alderson-Day, B., Smailes, D., Sterzer, P., Corlett, P. R., Leptourgos, P., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw075 · Cited by 157 · see citing works
Subtypes of Drug Abuse With Psychosis
Tsuang, M. T. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290020013003 · Cited by 161 · see citing works
Prediction error, ketamine and psychosis: An updated model
Corlett, P. R., Honey, G. D., & Fletcher, P. C. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116650087 · Cited by 142 · see citing works
“They do not, however, induce delusions (Young, 1974).”
Moreno, J. L., Kurita, M., Holloway, T. D., López, J., Cadagan, R., Martínez‐Sobrido, L., García‐Sastre, A., & González‐Maeso, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4230-10.2011 · Cited by 120 · see citing works
“…such as mescaline, psilocybin, and LSD, produce symptoms in normal subjects comparable to those seen in acutely ill unmedicated or first episode schizophrenics (Young, 1974; Vollenweider et al., 1998), and that hallucinogens aggravate hallucinations in schizophrenic patients (Hoch et al., 1952).”
BackgroundDreams, Hallucinogenic Drug States, and Schizophrenia: A Psychological and Biological Comparison
Fischman, L. G. (1983) · Schizophrenia Bulletin · doi:10.1093/schbul/9.1.73 · Cited by 108 · see citing works
“Young (1974) compared 20 recent onset schizophrenics (mean age — 19.5 years) with 20 age-, sex-, and occupation-matched , LSD subjects (and 20 matched controls ).”
InfluentialHallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects
Strassman, R. (1995) · Journal of Nervous and Mental Disease · doi:10.1097/00005053-199503000-00002 · Cited by 96 · see citing works
“However, the degree of overlap has been vigorously debated (Hollister, 1962; Langs and Barr, 1968; Vardy and Kay, 1983; Young, 1974).”
Backgroundde Bartolomeis, A., Buonaguro, E. F., & Iasevoli, F. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2921-8 · Cited by 89 · see citing works
“Hallucinogens-induced psychosis shows some similarities with acute schizophrenia, but fails to recapitulate all aspects of schizophrenia as a syndrome (Young 1974; Vollenweider et al. 1997; Gouzoulis-Mayfrank et al. 1998).”
BackgroundDysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects
Muguruza, C., Moreno, J. L., Umali, A., Callado, L. F., Meana, J. J., & González‐Maeso, J. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.10.006 · Cited by 86 · see citing works
“…psilocybin and lysergic acid diethylamide (LSD), produce in normal subjects symptom profiles comparable to those seen in acutely ill unmedicated or first-episode schizophrenics (Young, 1974; Hermle et al., 1992; Vollenweider et al., 1998; Gouzoulis-Mayfrank et al., 2005; Quednow et al., 2011).”
BackgroundPerceptual changes in schizophrenia: a questionnaire survey
Phillipson, O. T., & Harris, J. P. (1985) · Psychological Medicine · doi:10.1017/s0033291700005092 · Cited by 84 · see citing works
Animal Models of Schizophrenia: The Case for LSD-25*
CLARIDGE, G. S. (1978) · Schizophrenia Bulletin · doi:10.1093/schbul/4.2.186 · Cited by 60 · see citing works
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Jaster, A. M., & González‐Maeso, J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02274-x · Cited by 54 · see citing works
Carhart-Harris, R. L. (2007) · Neuropsychoanalysis · doi:10.1080/15294145.2007.10773557 · Cited by 56 · see citing works
“However, it has be shown that visual hallucinations are a much more prominent feature of early-onset psychosis and acute psychotic episodes (Chapman, 1966; Fischman, 1983; Freedman & Chapman, 1973; McCabe, Fowler, Cadoret, & Winokur, 1972; Young, 1974), and cross-cultural studies have shown that visual hallucinations…”
BackgroundKeane, B. P., Cruz, L. N., Paterno, D., & Silverstein, S. M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00069 · Cited by 53 · see citing works
“Disturbed color perception has been documented in earlier self-report studies (19, 49, 50); double or reversed”
BackgroundWießner, I., Falchi-Carvalho, M., Palhano-Fontes, F., Feilding, A., Ribeiro, S. T. G., & Tófoli, L. F. (2021) · Psychological Medicine · doi:10.1017/s0033291721002531 · Cited by 51 · see citing works
Phillipson, O. T., McKeown, J., Baker, J., & Healey, A. F. (1977) · The British Journal of Psychiatry · doi:10.1192/bjp.131.2.172 · Cited by 51 · see citing works
Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models
Shah, U. H., & González-Maeso, J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00044 · Cited by 44 · see citing works
Substance Abuse and Schizophrenia: Impediments to Optimal Care
Salloum, I. M., Salloum, H. B., & Salloum, D. C. (1991) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999109027556 · Cited by 47 · see citing works
Preclinical models of antipsychotic drug action
Moreno, J. L., & González‐Maeso, J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000606 · Cited by 29 · see citing works
“…features with schizophrenia, including: perceptual disturbances ; sensory processing; cognition; changes in brain metabolism; self-representation (Young, 1974; Hermle et al., 1992; Vollenweider et al., 1998; Gouzoulis- Mayfrank et al., 2005; Quednow et al., 2011; Carhart- Harris et al., 2012).”
Belli, S. R. (2009) · Personality and Individual Differences · doi:10.1016/j.paid.2009.01.016 · Cited by 28 · see citing works
Wießner, I., Falchi-Carvalho, M., Palhano-Fontes, F., Maia, L. O., Feilding, A., Ribeiro, S. T. G., Mota, N. B., de Araújo, D. B., & Tófoli, L. F. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06006-3 · Cited by 23 · see citing works
“Notably, several early, mostly preliminary or anecdotal observations described changes in the use and understanding of abstract content under LSD and psilocybin, for example within experience reports or proverb interpretations (Silverstein and Klee 1958; Leuner 1962, p. 36; Young 1974).”
BackgroundDifferential Diagnosis and Diagnostic Systems in Schizophrenia
Doran, A. R., Breier, A. F., & Roy, A. (1986) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30632-4 · Cited by 22 · see citing works
Kovar, K., Rösch, C., Rupp, A., & Hermle, L. (1990) · Pharmazie in unserer Zeit · doi:10.1002/pauz.19900190306 · Cited by 19 · see citing works
Some Compounds With Hallucinogenic Activity
Fanchamps, A. (1978) · Springer eBooks · doi:10.1007/978-3-642-66775-6_8 · Cited by 15 · see citing works
Hermle, L., & Krähenmann, R. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_460 · Cited by 14 · see citing works
Allen, S., Goodall, T., Jones, C. A., James, R., & Surtees, A. D. R. (2023) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgad002 · Cited by 12 · see citing works
“…(2016) 23 PCS 83% McKetin et al (2018) 33 PCS 41% Norman et al (2005) 34 PCS 83% Rajapakse et al (2011) 17 RCS 75% Solesvik et al (2016) 35 PCS 91% Young (1974) 36 PCS 50% Note: RCS, Retrospective Case Cohort Study; PCS, Prospective Case Cohort Study. which was PR = 0.40 (95% CI: 0.23 to 0.56)…”
InfluentialDrug-induced Psychoses and their Relationship to Schizophrenia
Davison, K. (1976) · Elsevier eBooks · doi:10.1016/b978-0-08-020928-9.50015-3 · Cited by 12 · see citing works
PET Imaging of the 5-HT2A Receptor System: A Tool to Study the Receptor’s In Vivo Brain Function
Herth, M. M., & Knudsen, G. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_5 · Cited by 10 · see citing works
Visual hallucinations in consultation-liaison neuropsychiatry
Walterfang, M., Mocellin, R., & Velakoulis, D. (2007) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2007.00239.x · Cited by 5 · see citing works
“Hallucinations caused by LSD and the related serotonergic compound mescaline characteristically begin as intensification of normal perceptual experience, leading to visual distortions and coloured shapes, progressing to complex VH of people and animals (80).”
BackgroundWalterfang, M., Mocellin, R., Copolov, D., & Velakoulis, D. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511789977.004 · Cited by 3 · see citing works
Metabotropic Glutamate 2 (mGlu2) Receptors and Schizophrenia Treatment
González‐Maeso, J. (2017) · The Receptors · doi:10.1007/978-3-319-56170-7_4 · Cited by 3 · see citing works
Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment
Moreno, J. L., & González‐Maeso, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_7 · Cited by 2 · see citing works
Roche, G. T. (2010) · doi:10.1002/9781444324440.ch2 · Cited by 2 · see citing works
Novel Targets for Drug Treatment in Psychiatry
Kurita, M., García‐Bea, A., & González‐Maeso, J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_30 · Cited by 1 · see citing works
REVIEW ARTICLE Complex visual hallucinations Clinical and neurobiological insights
Manford, M., & Andermann, F. (1998) · Cited by 1 · see citing works
Drogemißbrauch und Schizophrenie
Schneider, H. (1976) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02206622 · Cited by 1 · see citing works
CLARIDGE, G. S. (1980) · Nature · doi:10.1038/287270c0
- Authors
- YOUNG, B. G.
- Corresponding author
- YOUNG, B. G.
- Venue
- The British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1974-01-01
- Volume
- 124
- Issue
- 1
- Pages
- 64-74
- ISSN
- 0007-1250 (ISSN-L)
- OpenAlex
- W2084257157
- Cited by
- 42
- References
- 12
- Citations by year
- 2023: 2 · 2021: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 5 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The British Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- lysergic acid diethylamide, LSD, schizophrenia, psychedelic experience, phenomenology, emotional experience, delusions, hallucinations, cross-state comparison
- MeSH terms
- Adolescent, Adult, Body Image, Delusions, Female, Hallucinations, Humans, Lysergic Acid Diethylamide, Male, Memory, Motor Activity, Schizophrenia, Thinking, Time Perception, Visual Perception
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
